# Dapsone for Acute Ischemia Stroke Study

> **NCT01144650** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Cidat, S.A. de C.V.** · enrollment: 300 (estimated)

## Conditions studied

- Cerebral Stroke
- Cerebrovascular Accident, Acute
- Cerebrovascular Stroke
- Stroke, Acute
- Stroke

## Interventions

- **DRUG:** Dapsone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01144650
- **Lead sponsor:** Cidat, S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-11
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2010-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144650, "Dapsone for Acute Ischemia Stroke Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01144650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*